2021 | Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement | Park, Hanbit; Kang, Do-Yoon; Ahn, Jung-Min; Kim, Kyung Won; Wong, Anthony Y T; Lam, Simon C C; Yin, Wei-Hsian; Wei Jeng; Lee, Yung-Tsai; HSIEN-LI KAO ; MAO-SHIN LIN ; Tsung-Yu Ko ; Kim, Won-Jang; Kang, Se Hun; Ko, Euihong; Kim, Dae-Hee; Koo, Hyun Jung; Yang, Dong Hyun; Kang, Joon-Won; Jung, Seung Chai; Lee, Jae-Hong; Yun, Sung-Cheol; Park, Seung-Jung; Park, Duk-Woo | BMJ open | 10 | 7 | |